P-glycoprotein, multidrug resistance-associated proteins and human organic anion transporting polypeptide influence the intracellular accumulation of atazanavir.

Omar Janneh; Tariq Anwar; Christof Jungbauer; Stefan Kopp; Saye H Khoo; David J Back; Peter Chiba

doi:10.3851/IMP1399

P-glycoprotein, multidrug resistance-associated proteins and human organic anion transporting polypeptide influence the intracellular accumulation of atazanavir.

Omar Janneh, Tariq Anwar, Christof Jungbauer, Stefan Kopp, Saye H Khoo, David J Back, Peter Chiba

Universitätsinstitut für Transfusionsmedizin

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

35 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	965-974
Fachzeitschrift	ANTIVIRAL THERAPY
Jahrgang	14
Ausgabenummer	7
DOIs	https://doi.org/10.3851/IMP1399
Publikationsstatus	Veröffentlicht - 2009

Zugriff auf Dokument

10.3851/IMP1399

Dieses zitieren

@article{87573ac4260c4448b74338cd561189a0,

title = "P-glycoprotein, multidrug resistance-associated proteins and human organic anion transporting polypeptide influence the intracellular accumulation of atazanavir.",

keywords = "HIV PROTEASE INHIBITORS, REVERSE-TRANSCRIPTASE INHIBITORS, PRIMARY HUMAN-LYMPHOCYTES, BLOOD MONONUCLEAR-CELLS, IN-VITRO, BRAIN-BARRIER, SAQUINAVIR, MODULATION, DRUG, METABOLISM",

author = "Omar Janneh and Tariq Anwar and Christof Jungbauer and Stefan Kopp and Khoo, {Saye H} and Back, {David J} and Peter Chiba",

year = "2009",

doi = "10.3851/IMP1399",

language = "English",

volume = "14",

pages = "965--974",

journal = "ANTIVIRAL THERAPY",

issn = "1359-6535",

publisher = "International Medical Press ",

number = "7",

}

TY - JOUR

T1 - P-glycoprotein, multidrug resistance-associated proteins and human organic anion transporting polypeptide influence the intracellular accumulation of atazanavir.

AU - Janneh, Omar

AU - Anwar, Tariq

AU - Jungbauer, Christof

AU - Kopp, Stefan

AU - Khoo, Saye H

AU - Back, David J

AU - Chiba, Peter

PY - 2009

Y1 - 2009

KW - HIV PROTEASE INHIBITORS

KW - REVERSE-TRANSCRIPTASE INHIBITORS

KW - PRIMARY HUMAN-LYMPHOCYTES

KW - BLOOD MONONUCLEAR-CELLS

KW - IN-VITRO

KW - BRAIN-BARRIER

KW - SAQUINAVIR

KW - MODULATION

KW - DRUG

KW - METABOLISM

U2 - 10.3851/IMP1399

DO - 10.3851/IMP1399

M3 - Original Article

C2 - 19918100

SN - 1359-6535

VL - 14

SP - 965

EP - 974

JO - ANTIVIRAL THERAPY

JF - ANTIVIRAL THERAPY

IS - 7

ER -